메뉴 건너뛰기




Volumn 42, Issue 1-2, 2011, Pages 116-129

Challenges in the development of hydrate phases as active pharmaceutical ingredients - An example

Author keywords

Crystallization; Drying; Hydrates; Micronization; Phase transformations; Sieving

Indexed keywords

4 ( 4 [ 3 ( 5 FLUORO 3,4 DIHYDROXY 6 HYDROXYMETHYLTETRAHYDROPYRAN 2 YLOXY) 5 ISOPROPYL 1H PYRAZOL 4 YLMETHYL]PHENYL) N [ 2 HYDROXY 1,1 BIS(HYDROXYMETHYL)ETHYL]BUTYRAMIDE; SAR 474832; TETRAHYDROPYRAN DERIVATIVE; UNCLASSIFIED DRUG; WATER;

EID: 78650677446     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.11.001     Document Type: Article
Times cited : (25)

References (27)
  • 1
    • 0028948839 scopus 로고
    • A theoretical basis for a biopharmaceutics drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
    • G.L. Amidon, H. Lennernäs, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
    • (1995) Pharm. Res. , vol.12 , pp. 413-420
    • Amidon, G.L.1    Lennernäs, H.2    Shah, V.P.3    Crison, J.R.4
  • 2
    • 24944445980 scopus 로고    scopus 로고
    • Thermodynamics of non-stoichiometric pharmaceutical hydrates
    • J.-R. Authelin Thermodynamics of non-stoichiometric pharmaceutical hydrates Int. J. Pharm. 303 2005 37 53
    • (2005) Int. J. Pharm. , vol.303 , pp. 37-53
    • Authelin, J.-R.1
  • 3
    • 1842689072 scopus 로고    scopus 로고
    • Pharmaceutical evaluation of early development candidates "the 100 mg-approach"
    • S. Balbach, and C. Korn Pharmaceutical evaluation of early development candidates "the 100 mg-approach" Int. J. Pharm. 275 1-2 2004 1 12
    • (2004) Int. J. Pharm. , vol.275 , Issue.12 , pp. 1-12
    • Balbach, S.1    Korn, C.2
  • 4
    • 43249092894 scopus 로고    scopus 로고
    • Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state
    • C. Bhugra, and M.J. Pikal Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state J. Pharm. Sci. 97 2008 1329 1349
    • (2008) J. Pharm. Sci. , vol.97 , pp. 1329-1349
    • Bhugra, C.1    Pikal, M.J.2
  • 5
    • 0242288839 scopus 로고    scopus 로고
    • Influence of mechanical activation on the physical stability of salbutamol sulphate
    • K. Brodka-Pfeiffer, P. Langguth, P. Grass, and H. Häusler Influence of mechanical activation on the physical stability of salbutamol sulphate Eur. J. Pharm. Biopharm. 56 3 2003 393 400
    • (2003) Eur. J. Pharm. Biopharm. , vol.56 , Issue.3 , pp. 393-400
    • Brodka-Pfeiffer, K.1    Langguth, P.2    Grass, P.3    Häusler, H.4
  • 6
    • 0032999626 scopus 로고    scopus 로고
    • Assessment of disorder in crystalline powders - A review of analytical techniques and their application
    • G. Buckton, and P. Darcy Assessment of disorder in crystalline powders - a review of analytical techniques and their application Int. J. Pharm. 179 2 1999 141 158
    • (1999) Int. J. Pharm. , vol.179 , Issue.2 , pp. 141-158
    • Buckton, G.1    Darcy, P.2
  • 7
    • 0033025189 scopus 로고    scopus 로고
    • The relevance of the amorphous state to pharmaceutical dosage forms: Glassy drugs and freeze dried systems
    • D.Q. Craig, P.G. Royall, V.L. Kett, and M.L. Hopton The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems Int. J. Pharm. 179 1999 179 207
    • (1999) Int. J. Pharm. , vol.179 , pp. 179-207
    • Craig, D.Q.1    Royall, P.G.2    Kett, V.L.3    Hopton, M.L.4
  • 8
    • 64649104158 scopus 로고    scopus 로고
    • From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus
    • R.A. DeFronzo From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus Diabetes 58 2009 773 795
    • (2009) Diabetes , vol.58 , pp. 773-795
    • Defronzo, R.A.1
  • 11
    • 53549134244 scopus 로고    scopus 로고
    • Physicochemical, crystallographic, thermal, and spectroscopic behavior of crystalline and X-ray amorphous ciclesonide
    • M.P. Feth, J. Volz, U. Hess, E. Sturm, and R.P. Hummel Physicochemical, crystallographic, thermal, and spectroscopic behavior of crystalline and X-ray amorphous ciclesonide J. Pharm. Sci. 97 9 2008 3765 3780
    • (2008) J. Pharm. Sci. , vol.97 , Issue.9 , pp. 3765-3780
    • Feth, M.P.1    Volz, J.2    Hess, U.3    Sturm, E.4    Hummel, R.P.5
  • 12
    • 79251543641 scopus 로고    scopus 로고
    • New technology for the investigation of water vapor sorption-induced crystallographic form transformations of chemical compounds: A water vapor sorption gravimetry-dispersive Raman spectroscopy coupling
    • M.P. Feth, J. Jurascheck, M. Spitzenberg, J. Dillenz, G. Bertele, and H. Stark New technology for the investigation of water vapor sorption-induced crystallographic form transformations of chemical compounds: a water vapor sorption gravimetry-dispersive Raman spectroscopy coupling J. Pharm. Sci. 2010 10.1002/jps.22317 (early view)
    • (2010) J. Pharm. Sci.
    • Feth, M.P.1    Jurascheck, J.2    Spitzenberg, M.3    Dillenz, J.4    Bertele, G.5    Stark, H.6
  • 13
    • 0026222271 scopus 로고
    • Determination of specific surface area by the laser diffraction technique. Comparison with the Blaine permeability method
    • M. Frías, M.I. Sánchez de Rojas, M.P. Luxán, and N. García Determination of specific surface area by the laser diffraction technique. Comparison with the Blaine permeability method Chem. Conc. Res. 21 5 1991 709 717
    • (1991) Chem. Conc. Res. , vol.21 , Issue.5 , pp. 709-717
    • Frías, M.1    Sánchez De Rojas, M.I.2    Luxán, M.P.3    García, N.4
  • 14
    • 71649102101 scopus 로고    scopus 로고
    • Manipulating hydrate formation during high shear wet granulation using polymeric excipients
    • A.D. Gift, P.E. Luner, L. Luedeman, and L.S. Taylor Manipulating hydrate formation during high shear wet granulation using polymeric excipients J. Pharm. Sci. 98 12 2009 4670 4683
    • (2009) J. Pharm. Sci. , vol.98 , Issue.12 , pp. 4670-4683
    • Gift, A.D.1    Luner, P.E.2    Luedeman, L.3    Taylor, L.S.4
  • 15
    • 34247477624 scopus 로고    scopus 로고
    • Quantifying the degree of disorder in micronized salbutamol sulfate using moisture sorption analysis
    • M. Gorny, M. Jakobs, V. Mykhaylova, and N.A. Urbanetz Quantifying the degree of disorder in micronized salbutamol sulfate using moisture sorption analysis Drug Dev. Ind. Pharm. 33 2007 235 243
    • (2007) Drug Dev. Ind. Pharm. , vol.33 , pp. 235-243
    • Gorny, M.1    Jakobs, M.2    Mykhaylova, V.3    Urbanetz, N.A.4
  • 17
    • 8344275688 scopus 로고    scopus 로고
    • The synchrotron powder diffractometer at beamline B2 at HASYLAB/DESY: Status and capabilities
    • M. Knapp, C. Baehtz, H. Ehrenberg, and H. Fuess The synchrotron powder diffractometer at beamline B2 at HASYLAB/DESY: status and capabilities J. Synchrotron Radiat. 11 2004 328 334
    • (2004) J. Synchrotron Radiat. , vol.11 , pp. 328-334
    • Knapp, M.1    Baehtz, C.2    Ehrenberg, H.3    Fuess, H.4
  • 18
    • 0037074074 scopus 로고    scopus 로고
    • Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry
    • L. Mackin, R. Zanon, J.M. Park, K. Foster, H. Opalenik, and M. Demonte Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry Int. J. Pharm. 231 2002 227 236
    • (2002) Int. J. Pharm. , vol.231 , pp. 227-236
    • MacKin, L.1    Zanon, R.2    Park, J.M.3    Foster, K.4    Opalenik, H.5    Demonte, M.6
  • 19
    • 0032619840 scopus 로고    scopus 로고
    • New high temperature furnace for structure refinement by powder diffraction in controlled atmospheres using synchrotron radiation
    • L. Margulies, M.J. Kramer, R.W. McCallum, S. Kycia, D.R. Haeffner, J.C. Lang, and A.I. Goldman New high temperature furnace for structure refinement by powder diffraction in controlled atmospheres using synchrotron radiation Rev. Sci. Instrum. 70 1999 3554 3561
    • (1999) Rev. Sci. Instrum. , vol.70 , pp. 3554-3561
    • Margulies, L.1    Kramer, M.J.2    McCallum, R.W.3    Kycia, S.4    Haeffner, D.R.5    Lang, J.C.6    Goldman, A.I.7
  • 20
    • 0344172594 scopus 로고    scopus 로고
    • Micronization of pharmaceutical substances in a spiral jet mill
    • N. Midouxa, P. Hosek, L. Pailleres, and J.R. Authelin Micronization of pharmaceutical substances in a spiral jet mill Powder Technol. 104 2 1999 113 120
    • (1999) Powder Technol. , vol.104 , Issue.2 , pp. 113-120
    • Midouxa, N.1    Hosek, P.2    Pailleres, L.3    Authelin, J.R.4
  • 23
    • 0031743197 scopus 로고    scopus 로고
    • Origins of the unusual hygroscopicity observed in LY297802 tartrate
    • S.M. Reutzel, and V.A. Russell Origins of the unusual hygroscopicity observed in LY297802 tartrate J. Pharm. Sci. 87 12 1998 1568 1571
    • (1998) J. Pharm. Sci. , vol.87 , Issue.12 , pp. 1568-1571
    • Reutzel, S.M.1    Russell, V.A.2
  • 24
    • 78650677237 scopus 로고    scopus 로고
    • to be published
    • Rossen, K., et al., to be published.
    • Rossen, K.1
  • 25
    • 0033987278 scopus 로고    scopus 로고
    • Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide
    • M.D. Ticehurst, P.A. Basford, C.I. Dallman, T.M. Lukas, P.V. Marshall, G. Nichols, and D. Smith Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide Int. J. Pharm. 193 2 2000 247 259
    • (2000) Int. J. Pharm. , vol.193 , Issue.2 , pp. 247-259
    • Ticehurst, M.D.1    Basford, P.A.2    Dallman, C.I.3    Lukas, T.M.4    Marshall, P.V.5    Nichols, G.6    Smith, D.7
  • 27
    • 0029058533 scopus 로고
    • Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability
    • G.H. Ward, and R.K. Schultz Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability Pharm. Res. 12 5 1995 773 779
    • (1995) Pharm. Res. , vol.12 , Issue.5 , pp. 773-779
    • Ward, G.H.1    Schultz, R.K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.